JAMA Network
About the Study: In a comparative study of 11,681 US cancer clinical trial, industry-sponsored trials were more likely to focus on single-agent drug therapies, while federally sponsored trials were more likely to evaluate nontreatment interventions, multimodality treatment strategies, deescalation approaches, and therapies for rare cancers and children.
JAMA+ Trials
Explore JAMA+ Trials for editor-curated JAMA Network clinical trials, commentary, multimedia, and more, led by Editor in Chief Alison Huang, MD, MAS.
Journalists may find Dr Huang's email newsletter, JAMA+ Trials "Theme of the Month," and the JAMA+ Trials search page helpful in reporting.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
